-
Scientific Reports Apr 2024The challenges in water treatment include the need for efficient removal of pollutants like nitrate, which poses significant environmental and health risks. Alumina's...
The challenges in water treatment include the need for efficient removal of pollutants like nitrate, which poses significant environmental and health risks. Alumina's significance lies in its proven effectiveness as an adsorbent for nitrate removal due to its high surface area and affinity for nitrate ions. This study delves into the synthesis of differen nano-sized γ-alumina (γA1-5) employing diverse precursors and methods, including nepheline syenite, lime, aluminum hydroxide, precipitation, and hydrothermal processes at varying reaction times. Simultaneously, magnetite (FeO) nanoparticles and magnetite/γ-alumina nanocomposites (F/γA5) were synthesized using the co-precipitation method with varying weight ratios (n). Our primary objective was to optimize γ-alumina synthesis by comparing multiple methods, shedding light on the influence of different precursors and sources. Hence, a comprehensive adsorption study was conducted to assess the materials' efficacy in nitrate removal. This study fills gaps in the literature, providing a novel perspective through the simultaneous assessment of magnetite/alumina nanocomposites and pure alumina performance. Structural and morphological properties were studied employing XRD, FT-IR, FESEM, EDX, XRD, and VSM techniques. The conducted experiments for γA5, F/γA5, and F/γA5 nanocomposites showcased the optimum pH of 5 and contact time of 45 min for all samples. The influence of nitrate's initial concentration on the removal percentage was investigated with initial concentrations of 10 ppm, 50 ppm, and 100 ppm. γA5, F/γA5 and F/γA5 nanocomposites had 17.3%, 55%, and 70% at 10 ppm, 18%, 55.16%, and 74% at 50 ppm, and 8.6%, 53.1%, and 63%, respectively. The results highlighted that F/γA5 can be used as a remarkable adsorbent for wastewater treatment purposes.
PubMed: 38561453
DOI: 10.1038/s41598-024-58459-z -
The Journal of Clinical Pediatric... Mar 2024When dental pulp is exposed, it must be covered with a biocompatible material to form reparative dentine. The material used, besides being biocompatible, should have an...
When dental pulp is exposed, it must be covered with a biocompatible material to form reparative dentine. The material used, besides being biocompatible, should have an ideal surface structure for the attachment, proliferation and differentiation of dental pulp stem cells. This study aimed to evaluate the porosity of the microstructures of four pulp capping materials using micro-computed tomography (micro-CT). Biodentine, Bioaggregate, TheraCal and Dycal materials were prepared according to the manufacturer's instructions using 2 × 9 mm Teflon molds. A total of 60 samples, 15 in each group, were scanned using micro-CT. Open and closed pores and the total porosity of the microstructures of the materials were assessed. The findings obtained from the study were analyzed the Kruskal-Wallis test followed by the Mann-Whitney U test. The porosity of Bioaggregate was significantly higher than that of Biodentine, Dycal and TheraCal in all porosity values. While Biodentine did not show a statistically significant difference in open and total porosity values from either TheraCal or Dycal, closed porosity values of Dycal were significantly higher than those of Biodentine and TheraCal. Because of the affinity of cells to porous surfaces, the pulp capping materials' microstructure may affect the pulp capping treatment's success. From this perspective, the use of Bioaggregate in direct pulp capping may increase the success of treatment.
Topics: Humans; Dental Pulp Capping; X-Ray Microtomography; Porosity; Oxides; Pulp Capping and Pulpectomy Agents; Silicates; Calcium Compounds; Drug Combinations; Aluminum Compounds; Calcium Hydroxide; Hydroxyapatites; Minerals
PubMed: 38548638
DOI: 10.22514/jocpd.2024.038 -
Vaccines Mar 2024The adaptation of egg-derived H7N9 candidate vaccine virus (CVV) in the mammalian cell line is an approach to developing a high-growth virus strain for the mass...
MDCK-Adaptive Mutation of A169S Changes Glycosylation Pattern of Hemagglutinin and Enhances MDCK-Based H7N9 Vaccine Virus Production without Loss of Antigenicity and Immunogenicity.
The adaptation of egg-derived H7N9 candidate vaccine virus (CVV) in the mammalian cell line is an approach to developing a high-growth virus strain for the mass production of vaccine manufacturing. The adaptive mutations that occur in hemagglutinin (HA) are critical to the activity and potency of the vaccine virus. Previously, we identified a new mutation of A169S in the HA protein of an MDCK-adapted H7N9 vaccine virus (A/Anhui/2013, RG268); however, whether and how this mutation affects vaccine potency remain to be investigated. In this study, we serially passaged RG268 in MDCK cells and found that the HA titer and the TCID of the passaged virus RG268-M5 were 4-fold (HA units/50 μL) and 3.5-fold (log TCID/mL) higher than those of the original CVV. By inspecting tandem MS spectra, we identified a new glycosylation site at N167 near the receptor binding site of the HA protein of RG268-M5. Flow cytometry results revealed that RG268-M5 could efficiently infect MDCK cells and initiate viral protein replication as well as that of RG268. Though the new glycosylation site is in the antigenic epitope of viral HA protein, the HI assay result indicated that the antigenicity of RG268-M5 was similar to RG268. Additionally, immunizing mice with RG268-M5 mixed aluminum hydroxide could induce potent antibody responses against the homologous and heterologous H7N9 viruses in vitro whereas the titers were comparable with those from the RG268 group. These results provide in-depth structural information regarding the effects of site-specific glycosylation on virus properties, which have implications for novel avian influenza vaccine development.
PubMed: 38543924
DOI: 10.3390/vaccines12030291 -
Vaccines Feb 2024COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a recurrent endemic disease affecting the whole world. Since November...
Vaccine Based on Recombinant Fusion Protein Combining Hepatitis B Virus PreS with SARS-CoV-2 Wild-Type- and Omicron-Derived Receptor Binding Domain Strongly Induces Omicron-Neutralizing Antibodies in a Murine Model.
BACKGROUND
COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a recurrent endemic disease affecting the whole world. Since November 2021, Omicron and its subvariants have dominated in the spread of the disease. In order to prevent severe courses of disease, vaccines are needed to boost and maintain antibody levels capable of neutralizing Omicron. Recently, we produced and characterized a SARS-CoV-2 vaccine based on a recombinant fusion protein consisting of hepatitis B virus (HBV)-derived PreS and two SARS-CoV-2 wild-type RBDs.
OBJECTIVES
To develop a PreS-RBD vaccine which induces high levels of Omicron-specific neutralizing antibodies.
METHODS
We designed, produced, characterized and compared strain-specific (wild-type: W-PreS-W; Omicron: O-PreS-O), bivalent (mix of W-PreS-W and O-PreS-O) and chimeric (i.e., W-PreS-O) SARS-CoV-2 protein subunit vaccines. Immunogens were characterized in vitro using protein chemical methods, mass spectrometry, and circular dichroism in combination with thermal denaturation and immunological methods. In addition, BALB/c mice were immunized with aluminum-hydroxide-adsorbed proteins and aluminum hydroxide alone (i.e., placebo) to study the specific antibody and cytokine responses, safety and Omicron neutralization.
RESULTS
Defined and pure immunogens could be produced in significant quantities as secreted and folded proteins in mammalian cells. The antibodies induced after vaccination with different doses of strain-specific, bivalent and chimeric PreS-RBD fusion proteins reacted with wild-type and Omicron RBD in a dose-dependent manner and resulted in a mixed Th1/Th2 immune response. Interestingly, the RBD-specific IgG levels induced with the different vaccines were comparable, but the W-PreS-O-induced virus neutralization titers against Omicron (median VNT50: 5000) were seven- and twofold higher than the W-PreS-W- and O-PreS-O-specific ones, respectively, and they were six-fold higher than those of the bivalent vaccine.
CONCLUSION
Among the tested immunogens, the chimeric PreS-RBD subunit vaccine, W-PreS-O, induced the highest neutralizing antibody titers against Omicron. Thus, W-PreS-O seems to be a highly promising COVID-19 vaccine candidate for further preclinical and clinical evaluation.
PubMed: 38543863
DOI: 10.3390/vaccines12030229 -
Pharmaceutics Mar 2024Several alum-adjuvanted vaccines have been licensed in the past 40 years. Despite its extensive and continuous use, the immune mechanism of action of alum adjuvants is...
Several alum-adjuvanted vaccines have been licensed in the past 40 years. Despite its extensive and continuous use, the immune mechanism of action of alum adjuvants is not yet completely understood. Many different variables during the formulation process have been assessed as critical for alum-adjuvanted vaccines, although most of them are still not yet fully understood. The absence of a clear understanding of all the possible variables regulating the mechanism of action and the behavior that alum adjuvant imposes on the protein antigen may also be related to analytical challenges. For this reason, there is an urgent need for a fast and simple tool that is possible without a preliminary sample manipulation and is able to control the amount and the degree of antigen adsorption levels and their consistency across different production processes. This work attempts to develop new analytical tools with the aim of directly quantifying and assessing both the content and/or the purity of formulated alum-adsorbed antigens, without any preliminary sample manipulation (e.g., antigen desorption) being reported. In addition, the different confirmation/behavior in terms of the response to specific monoclonal antibodies in the presence of different ratios of alum-OH adsorbent antigens have been investigated. As a proxy to develop new analytical tools, three recombinant protein adsorbed models were used as follows: Neisseria adhesin A (NadA), Neisserial Heparin Binding Antigen (NHBA), and factor H binding protein (fHbp) as antigens, as well as aluminum hydroxide (AH) as an adjuvant system. The selection of the adjuvanted system model was dictated due to the substantial quantity of the literature regarding the protein structure and immunological activities, meaning that they are well characterized, including their adhesion rate to alum. In conclusion, three different analytical tools were explored to quantify, detect, and study the behavior of antigens in the presence of the alum adjuvant.
PubMed: 38543314
DOI: 10.3390/pharmaceutics16030420 -
Vaccine Apr 2024An issue with many current vaccines is the dependency on broadly inflammatory adjuvants, such as aluminum hydroxide or aluminum salts that affect many immune- and...
An issue with many current vaccines is the dependency on broadly inflammatory adjuvants, such as aluminum hydroxide or aluminum salts that affect many immune- and non-immune cells. These adjuvants are not necessarily activating all antigen-presenting cells (APCs) that take up the antigen and most likely they also activate APCs with no antigen uptake, as well as many non-immune cells. Conjugation of antigen and adjuvant would enable the use of smaller amounts of adjuvant and avoid unnecessary tissue damage and activation of bystander cells. It would ensure that all APCs that take up the antigen would also become activated and avoid that immature and non-activated APCs present the antigen to T cells without a co-stimulatory signal, leading to tolerogenesis. We have developed a novel vaccine that co-deliver antigen and a nucleotide adjuvant to the same APC and lead to a strong activation response in dendritic cells and macrophages. The vaccine is constructed as a fusion-protein with an antigen fused to the DNA/RNA-binding domain from the Hc2 protein from Chlamydia trachomatis. We have found that the fusion protein is able to package polyinosinic:polycytidylic acid (poly(I:C)) or dsDNA into small particles. These particles were taken up by macrophages and dendritic cells and led to strong activation and maturation of these cells. Immunization of mice with the fusion protein packaged poly(I:C) led to a stronger antibody response compared to immunization with a combination of poly(I:C) and antigen without the Hc2 DNA/RNA-binding domain.
Topics: Animals; Mice; Antibody Formation; Nucleotides; Dendritic Cells; Antigens; Vaccines; Poly I-C; Adjuvants, Immunologic; DNA
PubMed: 38538405
DOI: 10.1016/j.vaccine.2024.03.058 -
RSC Advances Mar 2024Currently, the most widely used material for solid rocket motor (SRM) insulation is ethylene propylene diene monomer (EPDM) filled with flame-retardant and...
Currently, the most widely used material for solid rocket motor (SRM) insulation is ethylene propylene diene monomer (EPDM) filled with flame-retardant and ablation-resistant fillers. Researchers have been working hard to find a flame-retardant filler that can simultaneously meet the complex requirements of mechanical strength, density, flame retardancy and ablative performance of the insulation layer. This requires research on the flame retardant properties of flame retardants in oxygen-poor environments. In this paper, ammonium polyphosphate (APP) is used as a flame retardant filler, which is filled into an EPDM premix (p-EPDM) containing fumed silica and aluminum hydroxide to prepare composite materials. By creating an anoxic environment, the flame retardant behavior of APP under anoxic conditions on EPDM was studied. The results show that composites prepared with APP show better flame retardant properties in tests such as limiting oxygen index and UL-94, with less impact on mechanical strength and density. The surface morphology and elemental composition of the composite combustion residues were studied using Raman spectroscopy, scanning electron microscopy (SEM) and energy dispersion spectroscopy (EDS). In an oxygen-depleted environment, APP will thermally decompose to form ammonia, water vapor and phosphorus-containing acidic substances. These gases dilute the flammable gas and reduce the thermal conductivity. The acidic substances containing phosphorus are concentrated on the surface of the pyrolysis layer to promote the formation of the carbon layer. This provides guidance for us to design insulation layer materials with properties that are more in line with actual use requirements.
PubMed: 38495995
DOI: 10.1039/d4ra00733f -
Frontiers in Cellular and Infection... 2024Chagas' is a neglected disease caused by the eukaryotic kinetoplastid parasite, Currently, approximately 8 million people are infected worldwide, most of whom are in...
Chagas' is a neglected disease caused by the eukaryotic kinetoplastid parasite, Currently, approximately 8 million people are infected worldwide, most of whom are in the chronic phase of the disease, which involves cardiac, digestive, or neurologic manifestations. There is an urgent need for a vaccine because treatments are only effective in the initial phase of infection, which is generally underdiagnosed. The selection and combination of antigens, adjuvants, and delivery platforms for vaccine formulations should be designed to trigger mixed humoral and cellular immune responses, considering that has a complex life cycle with both intracellular and bloodstream circulating parasite stages in vertebrate hosts. Here, we report the effectiveness of vaccination with a -specific protein family (TcTASV), employing both recombinant proteins with aluminum hydroxide and a recombinant baculovirus displaying a TcTASV antigen at the capsid. Vaccination stimulated immunological responses by producing lytic antibodies and antigen-specific CD4+ and CD8+ IFNɣ secreting lymphocytes. More than 90% of vaccinated animals survived after lethal challenges with , whereas all control mice died before 30 days post-infection. Vaccination also induced a strong decrease in chronic tissue parasitism and generated immunological memory that allowed vaccinated and infected animals to control both the reactivation of the infection after immunosuppression and a second challenge with . Interestingly, inoculation with baculovirus partially protected the mice against . In brief, we demonstrated for the first time that the combination of the baculovirus platform and the TcTASV family provides effective protection against i, which is a promising vaccine for Chagas disease.
Topics: Humans; Animals; Mice; Parasites; Baculoviridae; Antigens, Protozoan; Chagas Disease; Trypanosoma cruzi; Vaccination; Vaccines; Protozoan Vaccines
PubMed: 38481660
DOI: 10.3389/fcimb.2024.1297321 -
Frontiers in Immunology 2024Type I hypersensitivity, or so-called type I allergy, is caused by Th2-mediated immune responses directed against otherwise harmless environmental antigens. Currently,... (Review)
Review
Type I hypersensitivity, or so-called type I allergy, is caused by Th2-mediated immune responses directed against otherwise harmless environmental antigens. Currently, allergen-specific immunotherapy (AIT) is the only disease-modifying treatment with the potential to re-establish clinical tolerance towards the corresponding allergen(s). However, conventional AIT has certain drawbacks, including long treatment durations, the risk of inducing allergic side effects, and the fact that allergens by themselves have a rather low immunogenicity. To improve AIT, adjuvants can be a powerful tool not only to increase the immunogenicity of co-applied allergens but also to induce the desired immune activation, such as promoting allergen-specific Th1- or regulatory responses. This review summarizes the knowledge on adjuvants currently approved for use in human AIT: aluminum hydroxide, calcium phosphate, microcrystalline tyrosine, and MPLA, as well as novel adjuvants that have been studied in recent years: oil-in-water emulsions, virus-like particles, viral components, carbohydrate-based adjuvants (QS-21, glucans, and mannan) and TLR-ligands (flagellin and CpG-ODN). The investigated adjuvants show distinct properties, such as prolonging allergen release at the injection site, inducing allergen-specific IgG production while also reducing IgE levels, as well as promoting differentiation and activation of different immune cells. In the future, better understanding of the immunological mechanisms underlying the effects of these adjuvants in clinical settings may help us to improve AIT.
Topics: Humans; Desensitization, Immunologic; Hypersensitivity; Adjuvants, Immunologic; Allergens; Aluminum Hydroxide; Adjuvants, Pharmaceutic
PubMed: 38464539
DOI: 10.3389/fimmu.2024.1348305 -
The Science of the Total Environment May 2024This study proposed and examined a new process flowsheet for treating neutral mine drainage (NMD) from an open-pit gold mine. The process consisted of three sequential...
This study proposed and examined a new process flowsheet for treating neutral mine drainage (NMD) from an open-pit gold mine. The process consisted of three sequential stages: (1) in situ hydrotalcite (HT) precipitation; (2) low-cost carbon substrate driven microbial sulfate reduction; and (3) ferrosol reactive barrier for removing biogenic dissolved hydrogen sulfide (HS). For concept validation, laboratory-scale columns were established and operated for a 140-days period with key process performance parameters regularly measured. At the end, solids recovered from various depths of the ferrosol column were analysed for elemental composition and mineral phases. Prokaryotic microbial communities in various process locations were characterised using 16S rRNA gene sequencing. Results showed that the Stage 1 HT-treatment substantially removed a range of elements (As, B, Ba, Ca, F, Zn, Si, and U) in the NMD, but not nitrate or sulfate. The Stage 2 sulfate reducing bioreactor (SRB) packed with 70 % (v/v) Eucalyptus woodchip, 1 % (w/v) ground (<1 mm) dried Typha biomass, and 10 % (w/v) NMD-pond sediment facilitated complete nitrate removal and stable sulfate removal of ca. 50 % (50 g-SO m d), with an average HS generation rate of 10 g-HS md. The HS-removal performance of the Stage 3 ferrosol column was compared with a synthetic amorphous Fe-oxyhydroxide-amended sand control column. Although both columns facilitated excellent (95-100 %) HS removal, the control column only enabled a further ca. 10 % sulfate reduction, giving an overall sulfate removal of 56 %. In contrast, the ferrosol enabled an extra 99.9 % sulfate reduction in the SRB effluent, leading to a near complete sulfate removal. Overall, the process successfully eliminated a range of metal/metalloid contaminants, nitrate, sulfate (2500 mg-SO L in the NMD to <10 mg-SO L in the final effluent) and HS (>95 % removal). Further optimisation is required to minimise release of ferrous iron from the ferrosol barrier into the final effluent.
Topics: Hydrogen Sulfide; RNA, Ribosomal, 16S; Nitrates; Sulfates; Bioreactors; Aluminum Hydroxide; Magnesium Hydroxide
PubMed: 38460684
DOI: 10.1016/j.scitotenv.2024.171537